Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity (Q29465470)

From Wikidata
Jump to navigation Jump to search
scientific article
  • Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
edit
Language Label Description Also known as
English
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity
scientific article
  • Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Statements

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity (English)
0 references
0 references
0 references
0 references
0 references
0 references
Chenbo Zeng
Molly J Kirk
Kelsie Mozzoni
Colleen Silky
Courtney Rehak
Raymond Yurko
Gilbert Rishton
Hank Safferstein
Rolf Craven
Elizabeth Head
Harry LeVine
Susan M Catalano
12 November 2014

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit